Zenas BioPharma, Inc.
ZBIO
$34.50
-$2.57-6.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.50M | -52.22M | -33.57M | -52.60M | -38.61M |
| Total Depreciation and Amortization | 11.00K | 12.00K | 23.00K | 33.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.03M | 5.31M | 5.36M | 5.15M | 2.97M |
| Change in Net Operating Assets | -3.66M | 5.16M | -8.86M | 8.87M | 4.54M |
| Cash from Operations | -41.13M | -41.74M | -37.05M | -38.55M | -31.06M |
| Capital Expenditure | 0.00 | 0.00 | -18.00K | -74.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.04M | -112.29M | -86.26M | -3.66M | -26.76M |
| Cash from Investing | 40.04M | -112.29M | -86.27M | -3.74M | -26.76M |
| Total Debt Issued | 75.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 940.00K | 1.72M | 99.00K | 6.33M | 234.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.32M | -- | -- | -4.47M | -439.00K |
| Cash from Financing | 72.62M | 1.72M | 99.00K | 1.85M | 233.98M |
| Foreign Exchange rate Adjustments | 25.00K | -236.00K | -52.00K | 141.00K | -52.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.56M | -152.55M | -123.28M | -40.30M | 176.11M |